Sensus Healthcare Announces CMS Sets Rates Higher for SRT Reimbursement

NEXT STORY
Chinook Therapeutics Announces License Agreement with Morehouse School of Medicine for Development of Therapies in Kidney Diseases Disproportionately Affecting African Americans and Underserved Communities
PREV STORY
Klick Health Will Donate $1 Per View of Its 2020 Holiday Video to Sesame Workshop
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

INNATE PHARMA ANNOUNCES PUBLICATION ON NEXT GENERATION IMMUNOTHERAPIES TARGETING THE ADENOSINE PATHWAY IN “CELL REPORTS”

author_avatar
NASDAQ Market News

Apellis Announces Plans to Submit NDA for Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH)

author_avatar
NASDAQ Market News

Nuvectis Pharma Raises $15 Million and In-Licenses Exclusive Worldwide Rights to Novel Selective HSF1 Pathway Inhibitor from the CRT Pioneer Fund

author_avatar
NASDAQ Market News